ADVFN US – Market Content Editor
-
Chip Stocks Slide for a Fifth Straight Session as Mixed Bank Earnings Keep Wall Street Flat
U.S. stocks ended Tuesday little changed to slightly lower, as a continued pullback in semiconductor shares and a mixed batch of big-bank earnings kept investors cautious. The S&P 500 barely moved, while the Dow and the Nasdaq Composite posted modest declines. The main theme was uneven strength under the surface: Apple hit a record high…
-
Algorhythm Highlights Potential $70 Million Project Cash Value as Azure Energy Advances Renewable Power Development
Company Identifies Potential $7 Million Equity Proceeds from Strategic Sale of North Carolina 100 MW Project Fort Lauderdale, FL – Algorhythm Holdings, Inc. (the “Company”) (NASDAQ:RIME) – a diversified holding company and owner of Azure Energy, a renewable power plant developer (“Azure”), and SemiCab Holdings, an AI-enabled logistics provider, today provided details of one of…
-
ZenaTech Reports Over 27% Organic Growth Across Existing Drone as a Service Operations and Estimates Q3, 2026 Total Revenue in Range of C$13.4 Million to C$14.8 Million
Vancouver, British Columbia — ZenaTech, Inc. (NASDAQ:ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology solution provider specializing in AI (Artificial Intelligence) drone, Drone as a Service (DaaS), enterprise SaaS, and Quantum Computing solutions, announces organic revenue growth averaging 27.1% in 2026 across its DaaS operations. The metric measures organic revenue growth generated within the approximately…
-
DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division
Leading Health IT Company has Implemented Cost Control Measures and Refocused Remaining Workforce Towards ChemoFx® Commercialization with Hospital Systems, HMOs, GPOs and Cancer Centers TAMPA, FL – DataMeds AI, Inc. (NASDAQ:MEDS) (“DataMeds AI,” “DataMEDS SI,” “DataMEDS,” or the “Company”), a healthcare company leveraging its Health IT and physical infrastructure together with its super intelligence platform…
-
American Fusion Advances Texatron Fusion Testing as Four Commercial Proposals Remain Under Negotiation
American Fusion (USOTC:AMFN) has upgraded key equipment for its Texatron Fusion Engine testing programme while pursuing potential commercial deployments, scientific review and financing discussions. The developments indicate progress across several workstreams, although technical validation and binding customer agreements remain outstanding. Key Investor Takeaways Why AMFN Stock Is in Focus American Fusion has provided an operational…
-
NioCorp Secures 15-Year Critical Minerals Sales Agreement with Traxys, Supporting Elk Creek Financing Plans
NioCorp Developments (NASDAQ:NB) has signed a binding 15-year agreement with Traxys North America, extending commercial arrangements across its planned Elk Creek critical minerals production and potentially strengthening its position in financing discussions with the U.S. Export-Import Bank. Key Investor Takeaways Why NB Stock Is in Focus NioCorp Developments has reached a definitive commercial agreement with…
-
CANEX Metals Secures Court Ruling Invalidating Helix Joint Venture at Gold Basin Property
CANEX Metals (USOTC:NOMNF) has secured a British Columbia Supreme Court ruling declaring the Helix Resources joint venture agreement unenforceable, removing a legal dispute over rights to its Gold Basin gold project in Arizona as the company advances exploration and drilling preparations. Key Investor Takeaways Why NOMNF Stock Is in Focus CANEX Metals has confirmed that…
-
Rona Therapeutics Signs Global RNAi Licensing Agreement with Roche Worth Up to $1.16 Billion in Milestones
Roche (USOTC:RHHBY) has secured exclusive worldwide rights to Rona Therapeutics’ investigational ALK7-targeting RNA interference therapy for obesity and metabolic diseases, expanding its pipeline with a treatment approach focused on fat tissue rather than appetite regulation. Key Investor Takeaways Why RHHBY Stock Is in Focus Rona Therapeutics has granted Roche an exclusive worldwide licence to develop…
-
Rail Vision to Present AI Rail Safety Technology and Commercial Progress at LD Micro Conference
Rail Vision (NASDAQ:RVSN) will present its latest AI-powered railway safety solutions and commercial developments at the 20th Annual LD Micro Main Event on October 21, 2026, providing investors with an opportunity to assess its expanding product portfolio and North American market activities. Key Investor Takeaways Why RVSN Stock Is in Focus Rail Vision has confirmed…
-
Scinai Expands CDMO Business with $5.1 Million Manufacturing Agreement as Committed Orders Rise 300%
Scinai Immunotherapeutics (NASDAQ:SCNI) has secured a $5.1 million development and clinical manufacturing agreement with a US-listed biotechnology company, increasing its committed customer orders to approximately $7.6 million and improving revenue visibility through 2027. Key Investor Takeaways Why SCNI Stock Is in Focus Scinai Immunotherapeutics has expanded its contract development and manufacturing organisation (CDMO) business through…